SCHEMBL23740654

SCHEMBL23740654

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4oc5cc(-n6c7cc(-c8ccccc8)c8ccccc8c7c7c8ccccc8c(-c8ccccc8)cc76)ccc5c34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.34
MAPT P10636 4/20 0.32
KDM4E B2RXH2 3/20 0.32
MAPK1 P28482 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CA12 O43570 1/20 0.30
ALDH2 P05091 1/20 0.30
AKR1B1 P15121 1/20 0.30
MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23740471 0.98 PTGER4 (0.33) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL23740645 0.95 PTGER4 (0.32) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL23740656 0.94 TDP1 (0.33) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL24118940 0.92 TDP1 (0.32) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL21862800 0.91 MAPT (0.32) MAPTKDM4EMAPK1ALDH1A1HPGD
SCHEMBL21862725 0.91 PTGER4 (0.31) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL23740481 0.91 ALDH1A1 (0.32) MAPTKDM4EMAPK1ALDH1A1HPGD
SCHEMBL21667054 0.90 KDM4E (0.36) PTGER4MAPTKDM4EMAPK1ALDH1A1
SCHEMBL23740562 0.90 ALDH1A1 (0.32) MAPTKDM4EALDH1A1HSD17B10TP53
SCHEMBL23740474 0.90 ALDH1A1 (0.32) MAPTALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 PTGER4 1460/4885MAPT 967/4885KDM4E 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.